Core Viewpoint - Rosen Law Firm is urging investors of Synopsys, Inc. to secure legal counsel before the December 30, 2025 deadline for a class action lawsuit related to securities purchased between December 4, 2024, and September 9, 2025 [2] Group 1: Class Action Details - Investors who purchased Synopsys securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by December 30, 2025 [4] - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [5] Group 2: Case Allegations - The lawsuit alleges that Synopsys made materially false and misleading statements and failed to disclose adverse facts about its business and operations [6] - Specific claims include the negative impact of Synopsys' focus on artificial intelligence customers on its Design IP business, leading to poor financial results [6] - The lawsuit asserts that the misleading statements caused investors to suffer damages when the true information became public [6]

Core Viewpoint - Rosen Law Firm is urging investors of Jasper Therapeutics, Inc. to secure legal counsel before the November 18, 2025 deadline for a securities class action lawsuit related to the company's alleged misleading statements and failures in manufacturing compliance [1][5]. Group 1: Legal Action Details - Investors who purchased Jasper Therapeutics securities between November 30, 2023, and July 3, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by November 18, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a proven track record in securities class actions, highlighting its own success in recovering significant settlements for investors [4]. Group 2: Allegations Against Jasper Therapeutics - The lawsuit claims that Jasper Therapeutics made false and misleading statements regarding its manufacturing controls and compliance with cGMP regulations, which could negatively impact the clinical and commercial prospects of its products, particularly briquilimab [5]. - The alleged failures increased the risk of confounding results in ongoing studies and overstated the company's business and financial prospects [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of Cepton, Inc. to secure legal counsel before the December 8, 2025 deadline for a class action lawsuit related to securities claims [1][2]. Group 1: Class Action Details - The class action pertains to investors who purchased or sold Cepton common stock between July 29, 2024, and January 6, 2025, inclusive [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company and has recovered hundreds of millions for investors [4]. Group 3: Case Allegations - The lawsuit alleges that Cepton's management made materially false and misleading statements regarding the company's business and operations, including failing to disclose a credible third-party bid that valued Cepton at more than double the Koito Acquisition [5]. - The Board of Directors is accused of not adequately exploring the third-party offer and failing to disclose its terms, depriving shareholders of the opportunity to make an informed decision regarding the Koito Acquisition [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Avantor, Inc. common stock during the specified class period of the upcoming lead plaintiff deadline on December 29, 2025 [1]. Group 1: Class Action Details - Investors who bought Avantor common stock between March 5, 2024, and October 28, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To participate in the class action, investors can submit their information through the provided link or contact the law firm directly [3][6]. - A lead plaintiff must file a motion with the court by December 29, 2025, to represent other class members in the litigation [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 and has been consistently ranked among the top firms for securities class action settlements since 2013 [4]. Group 3: Case Allegations - The lawsuit alleges that Avantor's management misrepresented the company's competitive position and failed to disclose negative impacts from increased competition, leading to materially false and misleading statements about the company's business and prospects [5].

Core Viewpoint - 37 Capital Inc. has successfully closed the second tranche of its equity financing, raising a total of $62,500 through the issuance of 500,000 units at a price of $0.125 per unit, with each unit comprising one common share and one share purchase warrant [1][2] Financing Details - The financing raised $62,500, with 500,000 units issued at $0.125 each [1] - Each unit includes a warrant allowing the purchase of one common share at $0.15 for three years [1] - A forced exercise provision for the warrants will activate if the company's shares trade at $0.35 or above for 10 consecutive trading days after six months from issuance [1] Use of Proceeds - Funds from the financing will be allocated towards general working capital [2] Insider Transactions - An insider acquired 320,000 units from the financing, which is classified as a related party transaction [3] - The company is utilizing exemptions from formal valuation and minority shareholder approval requirements under Multilateral Instrument 61-101 [3] Regulatory Notes - All securities issued are subject to a hold period expiring on March 18, 2026 [2] - The Canadian Securities Exchange (CSE) has not reviewed the news release and does not accept responsibility for its accuracy [3]

Core Insights - Sage Potash Corp. announces the immediate departure of Rod Reum as Chief Financial Officer and the return of William Grossholz as Interim CFO [1][2] - The executive changes are part of Sage Potash's strategy for the next stage of development following the filing of its preliminary economic assessment technical report for the Sage Plain Potash Project [2] - The company is focused on establishing a secure and sustainable domestic potash production platform in the United States, emphasizing food security and environmental stewardship [3] Company Overview - Sage Potash Corp. is dedicated to the development of its flagship Sage Plain Potash Project located in the Paradox Basin, Utah, which has a large and high-grade resource base [3] - The company aims to create value for shareholders and stakeholders while maintaining strong financial governance as it executes its strategic objectives [2][3]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of James Hardie Industries plc during the specified class period of the upcoming lead plaintiff deadline on December 23, 2025 [2]. Group 1: Class Action Details - Investors who bought James Hardie common stock between May 20, 2025, and August 18, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the December 23, 2025 deadline [4]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [7]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting their own achievements in this area [5]. - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [5]. Group 3: Case Specifics - The lawsuit alleges that James Hardie Industries misled investors regarding the performance of its North America Fiber Cement segment, falsely claiming strong demand while being aware of distributor destocking [6]. - The misleading statements reportedly led to investor damages once the true situation was revealed [6].

Core Viewpoint - Rosen Law Firm is encouraging investors of Inspire Medical Systems, Inc. to secure legal counsel before the January 5, 2026 deadline for a securities class action lawsuit related to the company's stock performance during the specified class period [2][4]. Group 1: Class Action Details - The class period for the lawsuit is from August 6, 2024, to August 4, 2025, during which investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3][6]. - A class action lawsuit has already been filed, and investors wishing to serve as lead plaintiffs must act by January 5, 2026 [4][6]. Group 2: Allegations Against Inspire Medical - The lawsuit alleges that Inspire Medical misrepresented and failed to disclose critical information regarding the Inspire V sleep apnea device, including its actual market demand and the necessary steps for its launch [6]. - Defendants are accused of issuing materially false and misleading statements that led investors to believe in strong demand for the Inspire V device, resulting in investor damages when the true details became known [6]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [5]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [5].

Core Insights - Powermax Minerals Inc. has successfully completed listings on multiple international stock exchanges, enhancing its global visibility and accessibility to investors [1][3] - The primary listing remains on the Canadian Securities Exchange (CSE) under the ticker symbol PMAX, with additional listings on the OTCQB Venture Market in the U.S. under PWMXF, and various German exchanges [2][8] - The company aims to build a diversified global shareholder base and increase awareness among retail and institutional investors in North America and Europe [4] Company Updates - Powermax has engaged RedChip Companies Inc. for a 14-day marketing campaign, which will include a 30-second TV advertisement airing 40 times on Fox Business and CNBC [5][6] - The marketing services agreement with RedChip involves a one-time fee of USD $85,000, with no securities issued as compensation [6] - Additionally, Powermax has contracted InvestorBrandNetwork for a 12-month term starting November 15, 2025, for a total consideration of USD $125,000, focusing on corporate communications and media distribution [9][10] Business Focus - Powermax Minerals Inc. is focused on advancing rare earth element projects, holding options to acquire the Cameron REE Property and the Atikokan REE Property, as well as owning the Ogden Bear Lodge Project [11]

Core Insights - Cathedra Bitcoin Inc. has reported its financial results for the three months ending September 30, 2025, highlighting significant operational milestones and strategic growth in the bitcoin mining and hosting sector [1][3]. Financial Performance - Total revenue for the quarter reached C$5.5 million [7]. - The company recorded a net loss of C$0.8 million, which is a reduction of C$3.2 million compared to the same period in 2024 [7]. Operational Developments - Cathedra completed a 30:1 consolidation of its issued and outstanding subordinate voting shares and multiple voting shares to streamline its capital structure, with a record date of October 14, 2025 [7]. - The construction of a new 15 MW data center was completed on time and under budget, increasing the existing power capacity of the portfolio by 50% [3][7]. - The company is advancing its pipeline of high-potential sites to expand its bitcoin mining and hosting infrastructure [7]. Strategic Focus - The company is restructuring its customer mix of hosting clients to optimize performance and profitability [3]. - Cathedra aims to scale its energy infrastructure to meet the growing demand for bitcoin mining and hosting services while exploring other productive uses of its expanding power portfolio [3]. - The company emphasizes leveraging innovative power strategies to optimize efficiency and reduce costs in a dynamic market [3].